Contractor directory
UEI LBM4GLJNDK31 · CAGE 5LVP8

Kaleo, Inc.

Kaleo, Inc. received $99.8M in federal prime contract obligations in the 12 months ending Oct 5, 2026, up 284.1% from $26.0M the year before, and $129.3M since FY2022. Its largest customer is the Department of Health and Human Services.

Obligations, latest 12 months
$99.8M
up 284.1% vs. $26.0M
Since FY2022
$129.3M
2 awards
Awards with activity
2
Latest 12 months
Most recent action
Sep 28, 2026
First seen Apr 11, 2024

Contractor details

Unique Entity ID (UEI)
LBM4GLJNDK31
CAGE code
5LVP8
Headquarters
Glen Allen, VA
Business size
Other Than Small Business

As recorded on this UEI's most recent prime contract action in USAspending.gov. Confirm current registration and certifications in SAM.gov.

Obligations by fiscal year

Net prime contract obligations by federal fiscal year.

FY2024
$3.5M
FY2025
$26.0M
FY2026
$99.8M

Markets where it ranks top 10

Agency and NAICS markets where this UEI is one of the ten largest primes in the latest 12 months.

Top agencies

Funding agencies ranked by obligations since FY2022.

Funding agencyLatest 12 moSince FY2022
Department of Health and Human Services$99.8M$129.3M

Top NAICS codes

Industry codes agencies recorded on this contractor's awards, since FY2022.

NAICSIndustryLatest 12 moSince FY2022
541714Research and Development in Biotechnology (except Nanobiotechnology)$99.8M$129.3M

What it sells

Product and service codes (PSC) on this contractor's awards, since FY2022.

PSCDescriptionSince FY2022
AN11Health R&D services; Health Care services; Basic Research$96.1M
AN42Health R&D services; Health Care - other; Applied Research$33.3M

Recent awards

This contractor's newest prime contract awards, most recent first.

AwardAgencyObligatedAwarded
75A50126C00010
Department of Health and Human Services
THIS ACQUISITION WILL ALLOW BARDA TO INVEST PROJECT BIOSHIELD FUNDS FOR LATE-STAGE CLINICAL DEVELOPMENT, REGULATORY APPROVAL FOR 2-PAM AUTOINJECTORS (AS A DRUG/DEVICE COMBINATION…
$96.1MSep 28, 2026
75A50124C00010
Department of Health and Human Services
DEVELOPMENT OF A NOVEL PRALIDOXIME CHLORIDE AUTO-INJECTOR DEVICE
$3.5MApr 11, 2024

Prime contracts (award types A–D) from USAspending.gov through Oct 5, 2026. Subcontracts are not included. Net obligations include deobligations and corrections.

Ready to win more?

Ready to connect your pursuit work?

GovEagle gives BD directors, capture managers, and proposal teams one AI workspace from pipeline through proposal, with CMMC/FedRAMP Certified compliance built in.